Researchers rejoice over a massive funding breakthrough: 7 News Australia report video
UpFrontPSMA trial published in the Lancet Oncology: View the publication for UpFrontPSMA: An investigator-initiated, multicentre, open-label, randomised, phase 2 trial done at 11 Australian hospitals.
ProsTIC Director awarded Saul Hertz Award presented to Professor Michael Hofman by the Society of Nuclear Medicine and Molecular Imaging: The 2024 Saul Hertz, MD Award
